Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Vincenzo Iaconianni"'
Autor:
Manuel Gotti, Irene Defrancesco, Mario D’Angelo, Sabrina Basso, Luca Crotto, Alfredo Marinelli, Cristina Maccalli, Vincenzo Iaconianni
Publikováno v:
Frontiers in Immunology, Vol 11 (2020)
Chimeric Antigen Receptor-T cells (CAR-T) are considered novel biological agents, designed to selectively attack cancer cells expressing specific antigens, with demonstrated clinical activity in patients affected with relapsed/refractory B-cell malig
Externí odkaz:
https://doaj.org/article/2831880b954647fba1bebfca36b583de
Therapeutic apheresis (TA) includes a wide range of therapeutic procedures based on the separation of blood components and the collection of cells with therapeutic activity or the removal of unwanted plasma or cellular components involved in the etio
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::192fbf26fde3cd1f149fd27a030c1b02
http://hdl.handle.net/11573/1577179
http://hdl.handle.net/11573/1577179
Autor:
Francesca Saltarelli, Roberta Sala, Ignazio Majolino, Alessandro Andriani, Vincenzo Iaconianni, Vincenza Martini, Laura De Padua
Publikováno v:
Blood. 132:5845-5845
Autologous stem cell transplantation (ASCT) is a standard treatment for many hematological disorders. Since ASCT needs technical and professional skills, a start-up process should imply the application of a specific methodology to reduce time and cos
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::371da1b7747e54fd6af3de307543f297
https://doi.org/10.1182/blood-2018-99-115406
https://doi.org/10.1182/blood-2018-99-115406